SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5kan'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CMC_A_SAMA105_0 (MET REPRESSOR)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	5 / 10	ALA A 113 PHE A 87 GLY A 116 GLU A 89 ARG A 269	None	1.35A	1cmcA-5kanA: undetectable 1cmcB-5kanA: undetectable	1cmcA-5kanA: 14.24 1cmcB-5kanA: 14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CMC_B_SAMB105_0 (MET REPRESSOR)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	5 / 10	GLU A 89 ARG A 269 ALA A 113 PHE A 87 GLY A 116	None	1.38A	1cmcA-5kanA: undetectable 1cmcB-5kanA: undetectable	1cmcA-5kanA: 14.24 1cmcB-5kanA: 14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GTI_B_CCSB47_0 (GLUTATHIONE S-TRANSFERASE)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 7	LEU A 194 THR A 155 LEU A 251 GLY A 249	None	0.71A	1gtiB-5kanA: undetectable	1gtiB-5kanA: 20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQT_B_ACTB1867_0 (FPRA)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	4 / 4	ALA G 40 ARG G 38 GLN G 43 GLU G 46	None	0.72A	1lqtB-5kanG: undetectable	1lqtB-5kanG: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LQU_B_ACTB1424_0 (FPRA)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	4 / 4	ALA G 40 ARG G 38 GLN G 43 GLU G 46	None	0.75A	1lquB-5kanG: undetectable	1lquB-5kanG: 18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MJQ_C_SAMC199_0 (METHIONINE REPRESSOR)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	5 / 10	GLU A 89 ARG A 269 ALA A 113 PHE A 87 GLY A 116	None	1.41A	1mjqC-5kanA: undetectable 1mjqD-5kanA: undetectable	1mjqC-5kanA: 14.24 1mjqD-5kanA: 14.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOJ_C_FRDC305_1 (POL POLYPROTEIN PEPTIDE INHIBITOR)	5kan	16.G.07 LIGHT CHAIN (Homo sapiens)	4 / 5	LEU I 179 GLY I 128 PRO I 120 VAL I 132	None	0.91A	2aojA-5kanI: undetectable	2aojA-5kanI: 18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JAP_D_J01D1249_1 (CLAVALDEHYDE DEHYDROGENASE)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	5 / 12	LEU A 164 ILE A 252 ALA A 253 VAL A 202 TYR A 161	None	1.24A	2japD-5kanA: undetectable	2japD-5kanA: 23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PEO_F_CU9F301_2 (SOLUBLE ACETYLCHOLINE RECEPTOR)	5kan	16.G.07 LIGHT CHAIN (Homo sapiens)	4 / 6	GLN I 89 TYR I 36 GLN I 38 SER I 98	None	1.23A	3peoG-5kanI: undetectable	3peoG-5kanI: 22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EQ4_A_SALA601_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 7	LEU A 194 TYR A 195 ILE A 252 GLY A 134	None	0.93A	4eq4A-5kanA: undetectable	4eq4A-5kanA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EQL_A_SALA602_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 7	LEU A 194 TYR A 195 ILE A 252 GLY A 134	None	0.93A	4eqlA-5kanA: undetectable	4eqlA-5kanA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EQL_B_SALB602_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 7	LEU A 194 TYR A 195 ILE A 252 GLY A 134	None	0.94A	4eqlB-5kanA: undetectable	4eqlB-5kanA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L1W_A_STRA402_1 (ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 7	VAL A 182 ILE A 252 LEU A 70 LEU A 71	None	0.87A	4l1wA-5kanA: undetectable	4l1wA-5kanA: 22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L39_A_SALA602_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 6	LEU A 194 TYR A 195 ILE A 252 GLY A 134	None	0.92A	4l39A-5kanA: undetectable	4l39A-5kanA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L39_B_SALB601_1 (4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 7	LEU A 194 TYR A 195 ILE A 252 GLY A 134	None	0.92A	4l39B-5kanA: undetectable	4l39B-5kanA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	4qvnH-5kanG: undetectable 4qvnI-5kanG: undetectable	4qvnH-5kanG: 21.15 4qvnI-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 10	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.20A	4qvnV-5kanG: undetectable 4qvnW-5kanG: undetectable	4qvnV-5kanG: 21.15 4qvnW-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.17A	4qvpH-5kanG: undetectable 4qvpI-5kanG: undetectable	4qvpH-5kanG: 21.15 4qvpI-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.17A	4qvpV-5kanG: undetectable 4qvpW-5kanG: undetectable	4qvpV-5kanG: 21.15 4qvpW-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	4qvqH-5kanG: undetectable 4qvqI-5kanG: undetectable	4qvqH-5kanG: 21.15 4qvqI-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	4qvqV-5kanG: undetectable 4qvqW-5kanG: undetectable	4qvqV-5kanG: 21.15 4qvqW-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.18A	4qvyV-5kanG: undetectable 4qvyW-5kanG: undetectable	4qvyV-5kanG: 21.15 4qvyW-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	4qw0H-5kanG: undetectable 4qw0I-5kanG: undetectable	4qw0H-5kanG: 21.15 4qw0I-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	4qw0V-5kanG: undetectable 4qw0W-5kanG: undetectable	4qw0V-5kanG: 21.15 4qw0W-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.20A	4qw1H-5kanG: undetectable 4qw1I-5kanG: undetectable	4qw1H-5kanG: 21.15 4qw1I-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.20A	4qw1V-5kanG: undetectable 4qw1W-5kanG: undetectable	4qw1V-5kanG: 21.15 4qw1W-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	4qwuH-5kanG: undetectable 4qwuI-5kanG: undetectable	4qwuH-5kanG: 21.15 4qwuI-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	4qwuV-5kanG: undetectable 4qwuW-5kanG: undetectable	4qwuV-5kanG: 21.15 4qwuW-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B6I_A_ADNA302_1 (FLUORINASE)	5kan	16.G.07 LIGHT CHAIN (Homo sapiens)	4 / 7	THR I 97 TYR I 96 PRO I 95 THR I 93	None	1.36A	5b6iA-5kanI: undetectable	5b6iA-5kanI: 21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 11	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.17A	5bxnH-5kanG: undetectable 5bxnI-5kanG: undetectable	5bxnH-5kanG: 21.15 5bxnI-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.19A	5cz7V-5kanG: undetectable 5cz7W-5kanG: undetectable	5cz7V-5kanG: 21.15 5cz7W-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DB5_A_CYSA503_0 (CYSTEINE DESULFURASE)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 8	HIS A 75 ASN A 96 ARG A 224 THR A 65	None	1.25A	5db5A-5kanA: undetectable 5db5B-5kanA: undetectable	5db5A-5kanA: 20.62 5db5B-5kanA: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.16A	5l5fH-5kanG: undetectable 5l5fI-5kanG: undetectable	5l5fH-5kanG: 21.15 5l5fI-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	SER G 203 GLY G 149 THR G 150 ALA G 151 THR G 146	None	1.16A	5l5fV-5kanG: undetectable 5l5fW-5kanG: undetectable	5l5fV-5kanG: 21.15 5l5fW-5kanG: 23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NEK_B_AZMB302_1 (PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	4 / 8	ASP A 73 ASP A 68 HIS A 75 ARG A 229	None	1.02A	5nekB-5kanA: undetectable	5nekB-5kanA: 11.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6D8F_A_ACTA803_0 (UNCHARACTERIZED PROTEIN)	5kan	HEMAGGLUTININ HA1 (Influenza A virus)	3 / 3	GLU A 82 LEU A 118 ARG A 150	None None NAG A 403 ( 4.9A)	0.82A	6d8fA-5kanA: undetectable	6d8fA-5kanA: 17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DRZ_A_H8JA1206_0 (5HT2B RECEPTOR, BRIL CHIMERA)	5kan	16.G.07 HEAVY CHAIN (Homo sapiens)	5 / 12	VAL G 222 THR G 220 VAL G 226 GLY G 133 VAL G 167	None	0.99A	6drzA-5kanG: undetectable	6drzA-5kanG: 16.99

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CMC_A_SAMA105_0","MET REPRESSOR","5kan","HEMAGGLUTININ HA1","Influenza A virus",5,"ALA A 113;PHE A  87;GLY A 116;GLU A  89;ARG A 269","None","1.35A","1cmcA-5kanA:undetectable;1cmcB-5kanA:undetectable","1cmcA-5kanA:14.24;1cmcB-5kanA:14.24"],["1CMC_B_SAMB105_0","MET REPRESSOR","5kan","HEMAGGLUTININ HA1","Influenza A virus",5,"GLU A  89;ARG A 269;ALA A 113;PHE A  87;GLY A 116","None","1.38A","1cmcA-5kanA:undetectable;1cmcB-5kanA:undetectable","1cmcA-5kanA:14.24;1cmcB-5kanA:14.24"],["1GTI_B_CCSB47_0","GLUTATHIONE S-TRANSFERASE","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"LEU A 194;THR A 155;LEU A 251;GLY A 249","None","0.71A","1gtiB-5kanA:undetectable","1gtiB-5kanA:20.00"],["1LQT_B_ACTB1867_0","FPRA","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",4,"ALA G  40;ARG G  38;GLN G  43;GLU G  46","None","0.72A","1lqtB-5kanG:undetectable","1lqtB-5kanG:18.36"],["1LQU_B_ACTB1424_0","FPRA","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",4,"ALA G  40;ARG G  38;GLN G  43;GLU G  46","None","0.75A","1lquB-5kanG:undetectable","1lquB-5kanG:18.36"],["1MJQ_C_SAMC199_0","METHIONINE REPRESSOR","5kan","HEMAGGLUTININ HA1","Influenza A virus",5,"GLU A  89;ARG A 269;ALA A 113;PHE A  87;GLY A 116","None","1.41A","1mjqC-5kanA:undetectable;1mjqD-5kanA:undetectable","1mjqC-5kanA:14.24;1mjqD-5kanA:14.24"],["2AOJ_C_FRDC305_1","POL POLYPROTEIN;PEPTIDE INHIBITOR","5kan","16.G.07 LIGHT CHAIN","Homo sapiens",4,"LEU I 179;GLY I 128;PRO I 120;VAL I 132","None","0.91A","2aojA-5kanI:undetectable","2aojA-5kanI:18.18"],["2JAP_D_J01D1249_1","CLAVALDEHYDE DEHYDROGENASE","5kan","HEMAGGLUTININ HA1","Influenza A virus",5,"LEU A 164;ILE A 252;ALA A 253;VAL A 202;TYR A 161","None","1.24A","2japD-5kanA:undetectable","2japD-5kanA:23.18"],["3PEO_F_CU9F301_2","SOLUBLE ACETYLCHOLINE RECEPTOR;SOLUBLE ACETYLCHOLINE RECEPTOR","5kan","16.G.07 LIGHT CHAIN","Homo sapiens",4,"GLN I  89;TYR I  36;GLN I  38;SER I  98","None","1.23A","3peoG-5kanI:undetectable","3peoG-5kanI:22.14"],["4EQ4_A_SALA601_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"LEU A 194;TYR A 195;ILE A 252;GLY A 134","None","0.93A","4eq4A-5kanA:undetectable","4eq4A-5kanA:20.24"],["4EQL_A_SALA602_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"LEU A 194;TYR A 195;ILE A 252;GLY A 134","None","0.93A","4eqlA-5kanA:undetectable","4eqlA-5kanA:20.24"],["4EQL_B_SALB602_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"LEU A 194;TYR A 195;ILE A 252;GLY A 134","None","0.94A","4eqlB-5kanA:undetectable","4eqlB-5kanA:20.24"],["4L1W_A_STRA402_1","ALDO-KETO REDUCTASE FAMILY 1 MEMBER C2","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"VAL A 182;ILE A 252;LEU A  70;LEU A  71","None","0.87A","4l1wA-5kanA:undetectable","4l1wA-5kanA:22.73"],["4L39_A_SALA602_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"LEU A 194;TYR A 195;ILE A 252;GLY A 134","None","0.92A","4l39A-5kanA:undetectable","4l39A-5kanA:20.24"],["4L39_B_SALB601_1","4-SUBSTITUTED BENZOATES-GLUTAMATE LIGASE GH3.12","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"LEU A 194;TYR A 195;ILE A 252;GLY A 134","None","0.92A","4l39B-5kanA:undetectable","4l39B-5kanA:20.24"],["4QVN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","4qvnH-5kanG:undetectable;4qvnI-5kanG:undetectable","4qvnH-5kanG:21.15;4qvnI-5kanG:23.58"],["4QVN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.20A","4qvnV-5kanG:undetectable;4qvnW-5kanG:undetectable","4qvnV-5kanG:21.15;4qvnW-5kanG:23.58"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.17A","4qvpH-5kanG:undetectable;4qvpI-5kanG:undetectable","4qvpH-5kanG:21.15;4qvpI-5kanG:23.58"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.17A","4qvpV-5kanG:undetectable;4qvpW-5kanG:undetectable","4qvpV-5kanG:21.15;4qvpW-5kanG:23.58"],["4QVQ_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","4qvqH-5kanG:undetectable;4qvqI-5kanG:undetectable","4qvqH-5kanG:21.15;4qvqI-5kanG:23.58"],["4QVQ_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","4qvqV-5kanG:undetectable;4qvqW-5kanG:undetectable","4qvqV-5kanG:21.15;4qvqW-5kanG:23.58"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.18A","4qvyV-5kanG:undetectable;4qvyW-5kanG:undetectable","4qvyV-5kanG:21.15;4qvyW-5kanG:23.58"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","4qw0H-5kanG:undetectable;4qw0I-5kanG:undetectable","4qw0H-5kanG:21.15;4qw0I-5kanG:23.58"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","4qw0V-5kanG:undetectable;4qw0W-5kanG:undetectable","4qw0V-5kanG:21.15;4qw0W-5kanG:23.58"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.20A","4qw1H-5kanG:undetectable;4qw1I-5kanG:undetectable","4qw1H-5kanG:21.15;4qw1I-5kanG:23.58"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.20A","4qw1V-5kanG:undetectable;4qw1W-5kanG:undetectable","4qw1V-5kanG:21.15;4qw1W-5kanG:23.58"],["4QWU_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","4qwuH-5kanG:undetectable;4qwuI-5kanG:undetectable","4qwuH-5kanG:21.15;4qwuI-5kanG:23.58"],["4QWU_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","4qwuV-5kanG:undetectable;4qwuW-5kanG:undetectable","4qwuV-5kanG:21.15;4qwuW-5kanG:23.58"],["5B6I_A_ADNA302_1","FLUORINASE","5kan","16.G.07 LIGHT CHAIN","Homo sapiens",4,"THR I  97;TYR I  96;PRO I  95;THR I  93","None","1.36A","5b6iA-5kanI:undetectable","5b6iA-5kanI:21.73"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.17A","5bxnH-5kanG:undetectable;5bxnI-5kanG:undetectable","5bxnH-5kanG:21.15;5bxnI-5kanG:23.58"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.19A","5cz7V-5kanG:undetectable;5cz7W-5kanG:undetectable","5cz7V-5kanG:21.15;5cz7W-5kanG:23.58"],["5DB5_A_CYSA503_0","CYSTEINE DESULFURASE","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"HIS A  75;ASN A  96;ARG A 224;THR A  65","None","1.25A","5db5A-5kanA:undetectable;5db5B-5kanA:undetectable","5db5A-5kanA:20.62;5db5B-5kanA:20.62"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.16A","5l5fH-5kanG:undetectable;5l5fI-5kanG:undetectable","5l5fH-5kanG:21.15;5l5fI-5kanG:23.58"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"SER G 203;GLY G 149;THR G 150;ALA G 151;THR G 146","None","1.16A","5l5fV-5kanG:undetectable;5l5fW-5kanG:undetectable","5l5fV-5kanG:21.15;5l5fW-5kanG:23.58"],["5NEK_B_AZMB302_1","PEPTIDOGLYCAN N-ACETYLGLUCOSAMINE DEACETYLASE","5kan","HEMAGGLUTININ HA1","Influenza A virus",4,"ASP A  73;ASP A  68;HIS A  75;ARG A 229","None","1.02A","5nekB-5kanA:undetectable","5nekB-5kanA:11.71"],["6D8F_A_ACTA803_0","UNCHARACTERIZED PROTEIN","5kan","HEMAGGLUTININ HA1","Influenza A virus",3,"GLU A  82;LEU A 118;ARG A 150","None;None;NAG A 403 ( 4.9A)","0.82A","6d8fA-5kanA:undetectable","6d8fA-5kanA:17.83"],["6DRZ_A_H8JA1206_0","5HT2B RECEPTOR, BRIL CHIMERA","5kan","16.G.07 HEAVY CHAIN","Homo sapiens",5,"VAL G 222;THR G 220;VAL G 226;GLY G 133;VAL G 167","None","0.99A","6drzA-5kanG:undetectable","6drzA-5kanG:16.99"]]